CDC-RFA-EH17-1701PPHF17 Amend 1.pdf

Image Description: Centers for Disease Control

Centers for Disease Control

National Center for Environmental Health

Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by Prevention and Public Health Funds

CDC-RFA-EH17-1701PPHF17

Application Due Date: 04/20/2017

Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by Prevention and Public Health Funds

CDC-RFA-EH17-1701PPHF17

TABLE OF CONTENTS

Part I. Overview Information Federal Agency NameA.

Funding Opportunity TitleB.

Announcement TypeC.

Agency Funding Opportunity NumberD.

Catalog of Federal Domestic Assistance (CFDA) NumberE.

Dates F.

Executive Summary G.

Part II. Full Text Funding Opportunity Description A.

Award Information B.

Eligibility Information C.

Application and Submission Information D.

Review and Selection Process E.

Award Administration Information F.

Agency Contacts G.

Other Information H.

Glossary I.

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-EH17-1701PPHF17. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry

(ATSDR)

B. Funding Opportunity Title:

Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by Prevention and Public Health Funds C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg /CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf. Guidance on how CDC interprets the definition of research in the context of public health can be found at http://www.cdc.gov/od/science/integrity /docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf.

NCEH – Non-Research/PPHF

D. Agency Funding Opportunity Number:

CDC-RFA-EH17-1701PPHF17

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.753 Additional CFDA Number: 93.197 F. Dates:

1. Due Date for Letter of Intent (LOI): N/A

2. Due Date for Applications: 04/20/2017, 11:59 p.m. U.S. Eastern Standard

Time, at www.grants.gov.

3. Date for Informational Conference Call:

The second informational call for CDC-RFA-EH17-1701PPHF17 will be held on April 5, 2017 from 2:00pm to 3:00pm Eastern Daylight Time

Participants can join the call by dialing 1-855-644-0229 (Toll-free) and entering the following passcode:

526017

The PowerPoint slide presentation is available at: https://www.cdc.gov/nceh/lead/ under the section titled “What’s New”

G. Executive Summary:

1. Summary Paragraph:

The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2017 https://foa.grantsolutions.gov/www.grants.gov https://foa.grantsolutions.gov/www.grants.gov https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.grants.gov https://www.cdc.gov/nceh/lead/

The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2017 funds of approximately $4M from Budget Authority [BA] will be awarded through cooperative agreements to support childhood lead poisoning prevention activities including: blood lead testing, surveillance, and targeted population-based interventions. In addition, as part of this FOA, awardees will be expected to demonstrate that processes are in place to identify lead-exposed children and link them to recommended services. More specifically, awardees will be expected to work closely with other agencies, partners, other stakeholders serving children to ensure that a comprehensive system of referral, follow up and evaluation is in place for lead-exposed children.

a. Eligible Applicants: Limited

b. FOA Type: Cooperative Agreement

c. Approximate Number of Awards: 45 10 awards are expected in year 1; 45 awards are expected in years 2&3.

d. Total Project Period Funding: $35,000,000

e. Average One Year Award Amount: $400,000

f. Total Project Period Length: 3

g. Estimated Award Date: 09/30/2017

h. Cost Sharing and / or Matching Requirements: N No cost sharing or matching funds are required for this program. Although no statutory matching requirement for this FOA exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Part II. Full Text A. Funding Opportunity Description

Part II. Full Text

1. Background

a. Overview An estimated 535,000 children in the United States have blood lead levels (BLLs) at or above the reference value for blood lead established by CDC in 2012 (5 µg/dL). Of these, 150,000 children’s levels are ≥10 µg/dL. These children are at grave risk for the intellectual, behavioral, and academic deficits caused by lead.

The primary source of lead exposed children is their homes; some 38 million homes in the United States have lead-based paint hazards that can result in childhood lead poisoning. Low-income and minority children bear a disproportionate burden of this condition caused by unhealthy housing. In addition, some areas of the United States report that as many as 35% of children identified with high BLLs are exposed to lead via sources other than lead-based paint in their homes (e.g., such as items decorated or made with lead).

Public health action is needed to support activities to reduce lead exposures, childhood lead poisoning and to better understand the impact of blood lead levels in children.

b. Statutory Authorities This program is authorized under Sections 317(k) (2) and 317(B) of the Public Health Service Act (42 U.S.C. Sections 247b (k) (2)] and 247b-3(b)), as amended; Section 4002 of the Patient Protection and Affordable Care Act of 2010 (ACA), P. L. 111-148, (42 U.S.C. Section 300u-11).

c. Healthy People 2020

The National Center for Environmental Health (NCEH) of CDC within HHS is committed to achieving the health promotion and disease prevention objectives of “Healthy People 2020” found at https://www.healt hypeople.gov/. This FOA is committed to the Healthy People 2020 lead-related goals of reducing: (1) blood lead above CDC’s current reference level, and (2) mean blood lead levels in young children, as well as disparities in blood lead levels based on race, ethnicity and socioeconomic status as public health concerns.

This FOA also addresses the Healthy People 2020 focus areas of Maternal, Infant and Child Health, Injury and Violence Prevention, and Environmental Health.

d. Other National Public Health Priorities and Strategies This FOA also supports the National Prevention Strategy’s Healthy and Safe Community Environments.

Additional information can be found at https:// www.surgeongeneral.gov/ priorities/ prevention/ strategy/ healthy-and- safe-community-environments.html

e. Relevant Work The Lead Contamination Control Act of 1988 authorized the Centers for Disease Control and Prevention (CDC) to initiate program efforts to eliminate childhood lead poisoning in the United States. The CDC Childhood Lead Poisoning Prevention Program was created as a result of this act.

From 1990 to 2012, CDC awarded funds to State and local health departments to support childhood lead poisoning prevention programs. In 2009, with congressional acknowledgement, this mission was expanded to include a healthy homes initiative that addressed multiple childhood diseases and injuries in the home but with a continued focus on reaching the Health People goal of eliminating childhood lead poisoning.

In 2014, NCEH awarded 3-year funding for lead poisoning prevention programmatic activities under FOA CDC-RFA-EH14-1408PPHF14. This FOA was financed solely by 2014 Prevention and Public Health Funds.

2. CDC Project Description

a. Approach

Bold indicates project period outcome.

CDC-RFA- EH17-1701PPHF17

Logic Model: Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed partially by PPHF

Bold indicates project period outcome

Strategies and Activities Short-term Outcomes Long-Term Outcomes

Strengthen blood lead level testing

Develop and implement plan for blood lead testing of children

Strengthen Surveillance

Develop, implement, and maintain HHLPSS or equivalent surveillance system

Increased numbers of children less than 6 years (72 months) of age tested for blood lead.

Improved data usage that leads to a greater identification of geographic areas and populations at

Reduced mean BLL in children aged less than 6 years (72 months) of age

Reduction of blood lead in children aged less than 6 years (72 months) of age

Reduction in housing https://www.healthypeople.gov/ https://www.healthypeople.gov/ https://www.surgeongeneral.gov/priorities/prevention/strategy/healthy-and-safe-community-environments.html https://www.surgeongeneral.gov/priorities/prevention/strategy/healthy-and-safe-community-environments.html http://www.thomas.gov/cgi-bin/bdquery/z?d100:HR04939:@@@L&summ2=m&|TOM:/bss/d100query.html

Develop and implement blood lead data collection, data quality and dissemination plan Conduct analysis of surveillance data Establish and implement surveillance reporting system and dissemination plan

Strengthen population-based interventions

Develop and implement targeted population-based interventions Educate public, partners, and stakeholders about lead-related issues Develop and conduct trainings for lead workforce, partners, and other stakeholders Develop and maintain collaborative relationships with community, local, and state partners and stakeholders to address priority challenges and opportunities

Strengthen processes to identify lead-exposed children and linkage to services

Provide support and subject matter expertise to systems that identify, refer, provide services to, and follow lead-exposed children Collaborate with partners, stakeholders, and programs (e.g., early childhood education programs, social services, school high-risk for lead exposure.

Increased ability to target interventions (e.g. education and outreach) to high-risk geographic areas and populations.

Increased knowledge and awareness of public health professionals, lead prevention workforce, partners, and other stakeholders about lead prevention and interventions through lead prevention training programs.

Increased identification of children exposed to lead and linkage to recommended services.

with lead hazards

Improved academic outcomes for lead-exposed children

Reduced disparities in BLL based on race, ethnicity, or socio-economic status

Reduced societal costs associated with lead-exposures (e.g.

healthcare, special education, criminal justice system) systems, etc.) that can provide services to mitigate the effects of high blood lead levels Connect lead-exposed children to community services Conduct education and outreach to parents and providers of lead-exposed children

i. Purpose This funding is intended to support activities to reduce lead exposures and lead poisoning.

Activities include: screening, reporting of blood lead data to CDC, data management/surveillance, and targeted population-based interventions. Awardees will also be expected to demonstrate that processes are in place to identify lead-exposed children and link them to recommended services. Awardees will be expected to work closely with agencies, partners, and other stakeholders serving children to ensure that a comprehensive system of referral, case management, follow-up and evaluation is in place.

ii. Outcomes Applicants are expected to achieve and report the following short-term outcomes during the project period:

Increase the number of children less than 6 years (72 months) of age tested for blood lead.1.

Improve data usage that leads to a greater identification of geographic areas and populations at high-risk for lead exposed.

2.

Increase the ability to target interventions (e.g. education and outreach) to high-risk geographic areas and populations.

3.

Increase the knowledge and awareness of public health professionals, lead prevention workforce, partners, and other stakeholders about lead prevention and interventions through lead prevention training programs.

4.

Increase the identification of children exposed to lead and link them to recommended services.5.

iii. Strategies and Activities Applicants must use childhood lead poisoning prevention funding to accomplish the following four activities.

Strengthen Blood Lead Level Testing

In support of blood lead level testing, applicants should:

Develop and implement a plan for increasing blood lead testing of children less than 6 years (72 months) of age.

Develop and implement blood lead testing strategies, with special emphasis on achieving universal testing of Medicaid-enrolled children.

Strengthen Surveillance

Applicants are expected to implement a childhood lead poisoning surveillance system that can report to

CDC quarterly on the number of children who are exposed to lead in housing, the number of houses that are identified with lead, and the nature and extent of lead in housing. In addition applicants must:

Develop, implement, and maintain a HHLPSS or equivalent surveillance system that will collect, compile, and track blood lead data and lead hazards data.

Develop and implement a blood lead data collection, data quality and dissemination plan.

Conduct analyses of surveillance data.

Establish and implement surveillance reporting system and dissemination plan. Include information on how data will be collected, evaluated, reported, shared with partners, and disseminated to the public.

Strengthen Population-based Interventions

The following are population-based intervention activities that applicants should consider:

Develop and implement targeted population-based interventions.

Educate public, partners, and stakeholders about lead-related issues.

Develop and conduct trainings for lead workforce, partners, and other stakeholders.

Develop and maintain collaborative relationships with community, local, and state partners and stakeholders to address priority challenges and opportunities.

To assist in the development and implementation of appropriate interventions, collected data shall integrate or interface with other:

maternal child and environmental public health databases (e.g., immunization registries; Adult Blood Lead Epidemiology and Surveillance [ABLES]; National Electronic Disease Surveillance System [NEDSS]; Environmental Public Health Tracking Network; Medicaid; and Special Supplemental Nutrition Program for Women, Infants and Children [WIC]);

state and local housing and environmental quality authorities; and housing data including that for housing code enforcement agencies and publicly owned or subsidized properties and Housing and Urban Development (HUD) collaborative programs.

Strengthen processes to identify lead-exposed children and linkage to services

The following activities should be considered in support of identifying lead-exposed children and linking them to services:

Provide technical support and subject matter expertise to systems that identify, refer, provide services to, and follow lead-exposed children.

Organize regular meetings with partners, stakeholders, and programs (e.g., early childhood education programs, social services, school systems, etc.) that can provide services to mitigate the effects of high blood lead levels.

Connect lead-exposed children to services.

Conduct education and outreach to parents and providers of lead-exposed children and those who are considered at-risk.

*The program should ensure that grantees adequately and appropriately inform the public that such education and outreach (mass communication campaigns) were supported with Federal dollars (if applicable).

*Applicants shall use education and outreach activities to raise awareness about lead-related issues and are explicitly prohibited from using Federal dollars for lobbying purposes.

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

Applicants should engage other CDC-funded programs in their jurisdictions, particularly those with a focus

Applicants should engage other CDC-funded programs in their jurisdictions, particularly those with a focus on child health and/or environmental health, and leverage opportunities to reach targeted populations, share databases, deliver services, and achieve outcomes expected under this FOA. Examples of other CDC-funded programs include, but are not limited to:

Environmental Public Health Tracking Program http://www.cdc.gov/nceh/tracking/

National Institute of Occupational Safety and Health’s Adult Blood Lead Epidemiology Program

(ABLES)

https://www.cdc.gov/niosh/topics/ables/

State and local immunization and asthma programs and registries National Center for Birth Defects and Developmental Disabilities (NCBDDD) programs and registries

b. With organizations not funded by CDC:

Applicants should work with relevant organizations external to CDC that could extend their reach to targeted populations, interface with other databases, and help facilitate activities under this FOA. Letters of support/Memorandums of Understanding/Memorandums of Agreement stating agreed upon area of collaboration from relevant state officials and others should be included in the application.

Examples of such organizations are:

U.S Department of Housing and Urban Development Center for Medicaid Services (CMS) Special Supplemental Nutrition Program for Women, Infants and Children (WIC)

EPA

HRSA Title V grantees HRSA Federal Home Visiting Program Healthy Start Association Maternal and child health programs Early childhood education programs Community-based, nonprofit and/or faith-based organizations community organizations State and local health and housing agencies Private and public laboratories Hospitals and healthcare systems Academic Institutions Department of Energy (Weatherization) Accredited environmental health practitioners and their organizations

Strategies should be implemented for leveraging resources that include funds from other allowable federally funded programs and/or state, local, charity, nonprofit or for-profit entities, or internal agency resources.

Applicants are expected to create a capacity-building mechanism, with partners, that will provide training, education, technical support, mobilization, and consensus to improve the communities’ ability to detect lead sources and identify risks and provide appropriate and timely interventions.

2. Target Populations The target population for this program is children less than 6 years (72 months) of age. Priority should be http://www.cdc.gov/nceh/tracking/ https://www.cdc.gov/niosh/topics/ables/

The target population for this program is children less than 6 years (72 months) of age. Priority should be given to children disproportionately affected by lead exposures and lead poisoning, particularly those living in areas that include homes built before 1978, low-income or subsidized housing with suspected or known lead hazards, racial and ethnic minorities, and recent immigrants.

a. Health Disparities Applicants should consider underserved populations, including tribal, disabled, and English speakers of other languages (ESOL), as well as other populations, to ensure they benefit from the applicants’ childhood lead poisoning prevention activities.

iv. Funding Strategy Each award is not to exceed $445,000.

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy Evaluation and progress reports

Prepare a written assessment of the accomplishments, challenges and opportunities including a description of the problems encountered, lessons learned, potential improvements.

Strategies/Activities:

1) Strengthen Blood Lead Level Testing: Implement a plan for blood lead testing of children less than 6 years (72 months) of age.

Indicators for success: a completed blood lead testing plan that includes an emphasis on universal testing of Medicaid-enrolled children.

2) Strengthen Surveillance: Implement a surveillance reporting system and dissemination plan. Include information on how data will be collected, evaluated, reported, shared with partners, and disseminated to the public.

Indicators for success: establishment and operation of an active ongoing sustainable childhood lead poisoning surveillance/tracking system in grantees’ jurisdictions that collects person-specific and address-specific data, including multiple laboratory test results over various years and that assures the periodic screening of children who are exposed to lead; a completed surveillance plan outlining approaches for data collection, evaluation, timely reporting, and data sharing to both partners and the public.

3) Strengthen Population-based Interventions: maintain collaborative relationships with community, local, and state partners and stakeholders to address priority childhood lead poisoning prevention challenges and opportunities.

Indicators for success: documentation of ongoing community and partners/stakeholder meetings;

completed examples of lead prevention education and training materials; implementation of a process that ensures data is received and used by federal agencies and public health officials to target actions to areas where the risk for childhood lead poisoning is the highest.

4) Strengthen processes to identify lead-exposed children and linkage to services: identify, refer, provide services to, and follow lead-exposed children.

Indicators for success: implementation of a process that identifies lead-exposed children, provides guidance for the referral and follow-up care of children, and evaluates the timeliness and efficacy of these activities.

Outcomes:

1) Increased numbers of children less than 6 years (72 months) of age tested for blood lead.

Indicators for success: Increase in the percentage of children less than 6 years (72 months) of age tested for blood lead from the previous reporting period; Increase in the percentage of Medicaid-enrolled children less than 6 years (72 months) of age tested for blood lead since the previous reporting period.

Percent of Medicaid-enrolled one year-old children tested for blood lead levels during the reporting period

[calculation: (number of Medicaid-enrolled one year-old children tested for blood lead levels / total number of Medicaid-enrolled one year-old children in the jurisdiction)*100]

Percent of Medicaid-enrolled two year-old children tested for blood lead levels during the reporting period

[calculation: (number of Medicaid-enrolled two year-old children tested for blood lead levels / total number of Medicaid-enrolled two year-old children in the jurisdiction)*100]

Percent of all one and two year-old children (both Medicaid-enrolled and non-Medicaid-enrolled) tested for blood lead levels in the previous calendar year

[calculation: (number of children aged one and two years tested for blood lead in the previous calendar year / total number of children under three years of age in the jurisdiction in the previous calendar year)*100]

2) Improved availability and use of data that leads to improved identification of geographic areas and populations at high risk for lead exposures.

Indicators for success: 95% of the Awardees' data received by CDC is free of errors and missing information; the program is able to maintain 100% electronic reporting of blood lead data from laboratories; resources (e.g., GIS software) and data (e.g., blood lead surveillance, census, and tax assessor data) are used to analyze and report data.

Percent of laboratory-reported blood lead test results that are reported electronically [calculation: (number of laboratory-reported blood lead test results that are electronically reported / total number of laboratory-reported blood lead test results received during the reporting period)*100]

3) Increased ability to target interventions (e.g. education and outreach) to high-risk geographic areas and populations.

Indicators for success: community based partners (health care providers, grass roots organizations, nongovernment organizations [NGOs], others) and/or universities/colleges agree to participate in preparing for and assisting in population-based surveillance and targeted interventions.

Number of new partner organizations and institutions engaged in brainstorming, strategizing, planning, implementing, or evaluating interventions for lead poisoning prevention in targeted geographic areas during the reporting period Number of new partner organizations and institutions engaged in brainstorming, strategizing, planning, implementing, or evaluating interventions for lead poisoning prevention for targeted at-risk populations (to include low-income and immigrant/refugee children) during the reporting period Number of regularly scheduled and held meetings with partners and stakeholders during the reporting period Number of new memoranda of understanding – or equivalent documents like memoranda of agreement and joint work plans - related to population-based childhood lead surveillance enhancement and targeted interventions for lead poisoning prevention developed and signed during the reporting period

Number of new data-sharing agreements for enhanced population-based childhood lead surveillance developed and signed during the reporting period

4) Increased knowledge and awareness among the lay public, public health professionals, childhood lead prevention workforce members, and other partners and stakeholders about childhood lead poisoning and prevention interventions through tailored education and outreach.

Indicators for success: Increased education on and support for efforts aimed at institutionalizing primary prevention of childhood lead poisoning through control or elimination of lead sources among decision makers and the public.

Number of educational outreach events concerning lead poisoning risks and interventions delivered to the lay public held in targeted high-risk areas during the reporting period Number of mass communication campaigns directed at the lay public to increase knowledge and awareness of lead poisoning risks and interventions deployed during the reporting period Number of educational outreach events – including trainings – directed at public health professionals, clinical providers, and other lead prevention partners about childhood lead prevention and interventions held during the reporting period

5) Increased identification of lead-exposed children who receive appropriate linkages to recommended follow-up services.

Indicators for success: implementation of a process that identifies lead-exposed children, provides guidance for the referral and follow-up care of children with elevated BLLs, and evaluates the timeliness and efficacy of these activities.

Number of public health professionals and clinical providers who received guidance documents for follow-up care for children who are identified with elevated blood lead levels during the reporting period Percent of children less than 6 years (72 months) of age who are referred to or from your Program for recommended follow-up services within two weeks of a confirmed elevated blood lead test result during the reporting period

[calculation: (number of children with elevated blood lead levels referred for follow-up services / number of children with elevated blood lead levels)*100]

Percent of children less than 6 years (72 months) of age who received recommended follow-up services within two weeks of a referral for recommended follow-up services following a confirmed elevated blood lead test result during the reporting period

[calculation: (number of children with elevated blood lead levels who received referred follow-up services / number of children with elevated blood lead levels referred for follow-up services)*100]

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this FOA. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant) Plans for updating the Data Management Plan (DMP), if applicable, for accuracy throughout the lifecycle of the project. The DMP should provide a description of the data that will be produced using these FOA funds; access to data; data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additionalrequirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, within the first 6 months of award, as described in the Reporting Section of this FOA.

Awardees should provide a statement of commitment to develop and submit a DMP as required by the FOA prior to the start of data collection in their project narrative.

c. Organizational Capacity of Awardees to Implement the Approach The organizational capacity statement should describe how the applicant agency is organized to carry out the requirements of this announcement, the nature and scope of its work, and/or its capabilities. Applicants should include a detailed description of their experience in collecting, analyzing, and reporting data;

implementing surveillance systems; targeting prevention activities to high risk areas; and managing programs and staff. They should also describe their working agreements, as well as letters of intent or contracts with partners.

Applicants should provide an organizational chart and curriculm vitae for key personnel. Key personnel must have the level of education, experience, and/or skills necessary to successfully implement and complete the project.

Additional information includes the following:

Organizational chart Curriculum vitae for existing key personnel (or job descriptions for planned key personnel) Indirect cost rate agreements Letters of support

The applicant must create a separate file for the noted items and must name the file "Organizational Chart,” “CVs/Resumes," “Indirect Cost Rate Agreements,” and “Letters of Support” and upload to www.grants.gov.

d. Work Plan A work plan is a program management tool that provides program direction and guidance. It allows the project officer to monitor implementation of activities on progress on project period outcomes.

Applicants must have a work plan. No specific work plan template is required as long as it is clear how the components in the work plan crosswalk to the strategies and activities, outcomes, and evaluation performance measures presented in the logic model and the narrative sections of this FOA.

A sample work plan format is presented below.

Applicants must provide a separate detailed work plan of no more than 5 pages to describe work to be conducted in the first year of this award. A high-level work plan of no more than 5 pages should be included separately to describe work to be conducted in years two and three of the award.

https://www.cdc.gov/grants/additionalrequirements/ar-25.html

The table should be completed for each short-term outcome.

Below are 2 examples of filled out templates:

Example #1

Short-term Outcome: [from Outcomes section and/or logic model] Increased number of children less than 6 years (72 months) of age tested for blood lead

Strategies and Activities

Process Measure [from

Evaluation and

Performance Measurement section]

Direction of Change

Not started

In progress

Completed

Baseline Target Responsible Position /

Party

Completion Date

Develop and implement plan for blood lead testing of children

1. Plan for blood lead testing is completed

Completed N/A N/A Epidemiologist and Program Manager

09/29/2018

Example #2

Short-term Outcome: [from Outcomes section and/or logic model] Increased knowledge and awareness of public health professionals, lead prevention workforce, partners, and other stakeholders about lead prevention and interventions through lead prevention training programs

Strategies and Activities

Process Measure [from Evaluation and Performance Measurement section]

Direction of Change

Not started

In progress

Completed

Baseline Target Responsible Position /

Party

Completion Date

Develop and maintain collaborative relationships with community, local, and state

1. Number of community and partner/stakeholder meetings

In progress

1 4 Program Manager state partners and stakeholders to address priority challenges and opportunities Develop and maintain collaborative relationships with community, local, and state partners and stakeholders to address priority challenges and opportunities

1. Number of memorandums of agreement (MOUs) or signed

Not started null 1 Program Manager

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and awardees, site visits, and awardee reporting (including work plans, performance, and financial reporting). Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking awardee progress in achieving the desired outcomes.

Ensuring the adequacy of awardee systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that awardees are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with awardees on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk grantees.

f. CDC Program Support to Awardees (THIS SECTION APPLIES ONLY TO COOPERATIVE

AGREEMENTS)

CDC will:

CDC will:

Support awardees in the development/enhancement and implementation of their lead poisoning surveillance programs.

Review the use of data and information collection methods and analysis instruments specific to the use of CDC HHLPSS.

Provide guidance in implementing activities, and will identify major program issues, strategies, and priorities related to the cooperative agreement.

Provide technical assistance in assessing program effectiveness.

Promote collaboration with other federal, state, and local health; environmental; and housing agencies by initiating contacts, conference calls, and on-site visits to discuss programmatic issues.

Provide HHLPSS at no cost, support awardees in deployment of the system and migration of data from other systems to HHLPPS, and provide ongoing maintenance of the system. (Note: Many states previously established HHLPSS under CDC-funded cooperative agreements.)

Provide assistance in the evaluation of surveillance activities and reporting and disseminating reports to partners.

Provide consultation and technical regarding techniques and approaches used to deliver or render services.

Review the use of data and information collected to support development, enhancement or implementation of population-based interventions and/or designating areas as lead-safe.

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the CDC Program

Support to Awardees Section.

2. Award Mechanism: UE2 UE2 - Emergency and Environmental Health Services - Cooperative Agreement

3. Fiscal Year: 2017

4. Approximate Total Fiscal Year Funding:

$4,000,000

5. Approximate Project Period Funding:

$35,000,000

This amount is subject to the availability of funds.

Estimated Total Funding: $35,000,000

6. Total Project Period Length:

3 year(s)

7. Expected Number of Awards:

10 awards are expected in year 1; 45 awards are expected in years 2&3.

8. Approximate Average Award:

$400,000 Per Budget Period

9. Award Ceiling: $445,000 Per Budget Period

This amount is subject to the availability of funds.

$445,000 (If the request is over $445,000, the application will be considered nonresponsive.)

$445,000 (If the request is over $445,000, the application will be considered nonresponsive.)

10. Award Floor: $150,000 Per Budget Period

11. Estimated Award Date: 09/30/2017

12. Budget Period Length: 12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the awardee (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Eligibility Category:

Government Organizations:

State governments or their bona fide agents (includes the District of Columbia) Local governments or their bona fide agents

2. Additional Information on Eligibility This FOA is limited to State Governments or their Bona Fide Agents and Local Governments or their Bona Fide Agents. Local governments or their Bona Fide Agents must have a valid population size of at least 750,000 using 2010 U.S. Census data or a 2011-2016 U.S. Census data update.

3. Justification for Less than Maximum Competition This funding opportunity announcement (FOA) is to support a limited competition to State and local governments or their Bona Fide Agents under the authority of: Sections 317(k) (2) and 317(B) of the Public Health Service Act (42 U.S.C. Sections 247b (k) (2)] and 247b-3(b)), as amended; Section 4002 of the Patient Protection and Affordable Care Act of 2010 (ACA), P. L. 111-148, (42 U.S.C. Section 300u-11).

This FOA supports activities related lead poisoning prevention with a focus on using blood surveillance data to identity and implement appropriate interventions to population at highest risk. Awardees must able to assure that follow-up is provided for lead-exposed children and/or cases of lead poisoning. Awardees must have the authority in their jurisdiction(s) to govern, regulate, deliver, implement, and enforce policies, codes or requirements on childhood lead poisoning prevention that could involve Medicaid, housing, environmental regulation, or consumer protection agencies. State and local governments or their Bona Fide Agents are the only entities with these authorities to achieve the mission of this FOA.

4. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

No cost sharing or matching funds are required for this program. Although no statutory matching requirement for this FOA exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

5. Maintenance of Effort Maintenance of effort is not required for this program.

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC.

If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the “Get Registered” option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

http://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://www.sam.gov/portal/public/SAM/ http://grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://www.grants.gov/

Step System Requirements Duration Follow Up

1 Data Universal Number System

(DUNS)

1. Click on http:// fedgov.dnb.com/ webform

2. Select Begin

DUNS

search/request process

3. Select your country or territory and follow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under DUNS number

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at (http:// fedgov.dnb.com/ webform) or call 1-866-705-5711Image Description:

2 System for Award Management

(SAM)

formerly Central Contractor Registration

(CCR)

1. Retrieve organizations DUNS number

2. Go to www.sam.gov and designate an E-Biz POC (note CCR username will not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fsd.gov/ fsd-gov/ home.do Calls:

866-606-8220Image Description:

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to

Same day but can take 8 weeks to be fully registered and approved

Register early! Log into grants.gov and check AOR status until it shows you have been approved http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://www.sam.gov https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do become an authorized organization representative

(AOR)

2. Once the account is set up the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization in the system (note, applicants

MUST

obtain a

DUNS

number and SAM account before applying on grants.gov)

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC OGS staff at 770-488-2700Image Description: or e-mail OGS ogstims@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348Image Description: .

4. Submission Dates and Times If the application is not submitted by the deadline published in the FOA, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline.

The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by OGS.

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: N/A

b. Application Deadline Due Date for Applications: 04/20/2017 , 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Date for Information Conference Call http://www.grants.gov http://www.grants.gov mailto:ogstims@cdc.gov

The second informational call for CDC-RFA-EH17-1701PPHF17 will be held on April 5, 2017 from 2:00pm to 3:00pm Eastern Daylight Time

Participants can join the call by dialing 1-855-644-0229 (Toll-free) and entering the following passcode:

526017

The PowerPoint slide presentation is available at: https://www.cdc.gov/nceh/lead/ under the section titled “What’s New”

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

Duplication of Efforts Applicants are responsible for reporting if this application will result in programmatic, budgetary, or commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract) submitted to another funding source in the same fiscal year. Programmatic overlap occurs when (1) substantially the same project is proposed in more than one application or is submitted to two or more funding sources for review and funding consideration or (2) a specific objective and the project design for accomplishing the objective are the same or closely related in two or more applications or awards, regardless of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g., equipment, salaries) are requested in an application but already are provided by another source.

Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted. Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.

Report Submission: The applicant must upload the report in Grants.gov under “Other Attachment Forms.”

The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent Letter of intent is not required

8. Table of Contents (There is no page limit. The table of contents is not included in the project narrative page limit.): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and https://www.cdc.gov/nceh/lead/ http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://www.grants.gov http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx upload it as a PDF file under "Other Attachment Forms" at…